Research Site 23 — Omaha, Nebraska

Research Site 23 is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site 23 has participated in 1 clinical trials.

Therapeutic areas: Severe Hypertriglyceridemia.

Sponsors: Arrowhead Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 23?

Research Site 23 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 23 conducted?

Research Site 23 has 1 clinical trials on record. Their work covers Severe Hypertriglyceridemia.

Is Research Site 23 accredited by Crixeo Health?

Research Site 23 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 23?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.